You've admitted that you know nothing. You keep repeating the same nonsense mantra year after year.
Buy when you can and never sell.
Great investment strategy for a growing, profitable company, perhaps, but not a pink sheet company that's not reporting and has been losing $5 million a year for a decade or so.
There is no evidence of a sudden change of path especially if the R&D people depart.